| 查看: 1381 | 回复: 17 | |||
[交流]
开发一种新药的惊人花费（The truly staggering cost of inventing new drugs）
|
|||
|
原文链接：http://bioluminor.biomart.cn/news/2770272.htm During the Super Bowl, a representative of the pharmaceutical company Eli Lilly posted the on the company’s corporate blog that the average cost of bringing a new drug to market is $1.3 billion, a price that would buy 371 Super Bowl ads, 16 million official NFL footballs, two pro football stadiums, pay of almost all NFL football players, and every seat in every NFL stadium for six weeks in a row. This is, of course, ludicrous. The average drug developed by a major pharmaceutical company costs at least $4 billion, and it can be as much as $11 billion. The drug industry has been tossing around the $1 billion number for years. It is based largely on a study (supported by drug companies) by Joseph DiMasi of Tufts University. It’s a nice number for the pharmaceutical industry, because it seems to justify the idea that medicines should be pricey (and increasingly, they can be very pricey, costing tens of thousands of dollars per patient per year) without making it seem that inventing new medicines is so expensive an endeavor as to be ultimately futile. But as Bernard Munos of the InnoThink Center for Research In Biomedical Innovation has noted, just adjusting that estimate for current failure rates results in an estimate of $4 billion in research dollars spent for every drug that is approved. But Munos showed me another figure, where he divided each drug company’s R&D budget by the average number of drugs approved. This was far more dramatic. The range of money spent is stunning. AstraZeneca has spent $12 billion in research money for every new drug approved, as much as the top-selling medicine ever generated in annual sales; Amgen spent just $3.7 billion. At $12 billion per drug, inventing medicines is a pretty unsustainable business. At $3.7 billion, you might just be able to make money (a new medicine can probably keep generating revenue for ten years; invent one a year at that rate and you’ll do well). There are lots of expenses here. A single clinical trial can cost $100 million at the high end, and the combined cost of manufacturing and clinical testing for some drugs has added up to $1 billion. But the main expense is failure. AstraZeneca does badly by this measure because it has had so few new drugs hit the market. Eli Lilly spent roughly the same amount on R&D, but got twice as many new medicines approved over that 15 year period, and so spent just $4.5 billion per drug. Wanting to make this even more rigorous, Forbes (that would be Scott DeCarlo and me) took Munos’ count of drug approvals for the major pharmas and combined it with their research and development spending as reported in annual earnings filings going back fifteen years, pulled from a Thomson Reuters database using FactSet. We adjusted all the figures for inflation. Using both drug approvals and research budgets since 1997 keeps the estimates being skewed by short-term periods when R&D budgets or drug approvals changed dramatically. The range of money spent is stunning. AstraZeneca has spent $12 billion in research money for every new drug approved, as much as the top-selling medicine ever generated in annual sales; Amgen spent just $3.7 billion. At $12 billion per drug, inventing medicines is a pretty unsustainable business. At $3.7 billion, you might just be able to make money (a new medicine can probably keep generating revenue for ten years; invent one a year at that rate and you’ll do well). There are lots of expenses here. A single clinical trial can cost $100 million at the high end, and the combined cost of manufacturing and clinical testing for some drugs has added up to $1 billion. But the main expense is failure. AstraZeneca does badly by this measure because it has had so few new drugs hit the market. Eli Lilly spent roughly the same amount on R&D, but got twice as many new medicines approved over that 15 year period, and so spent just $4.5 billion per drug. |
回复此楼» 猜你喜欢
见刊快的中文核心期刊
已经有2人回复
-
一志愿天中医中药学专硕，希望有b区的老师可以考虑一下我
已经有1人回复
-
药物学论文润色/翻译怎么收费?
已经有253人回复
-
调剂
已经有3人回复
-
药学学硕326求调剂
已经有0人回复
-
26年博士申请
已经有20人回复
-
求助 苯磷硫胺JP
已经有0人回复
-
100金币 阿莫西林克拉维酸钾片BP药典中提到的克拉维酸聚合物具体结构式是啥？
已经有2人回复
-
膳食补充剂合规性交流
已经有0人回复
-
一志愿浙大药学求调剂
已经有0人回复
-
高温高压反应求助
已经有4人回复
» 抢金币啦！回帖就可以得到:
-
【招聘】温州医科大学/附属医院/瓯江实验室李校堃院士团队诚聘博士后和科研人员
+1/195
-
【招聘】温州医科大学/附属医院/瓯江实验室李校堃院士团队诚聘博士后和科研人员
+1/191
-
西南科大辐射防护材料课题组接收材料与化学背景硕士研究生
+3/152
-
求助紫外可见分光光度计
+1/99
-
多通道数据采集/线性功率放大器租赁｜自动化控制实验
+1/96
-
赣南师范大学肖兴教授课题组招2026级电子信息硕士 4-6 名，欢迎调剂
+1/82
-
招聘︱国家纳米科学中心丁宝全杰青团队诚聘博士后（特别研究助理）
+2/38
-
浙江省人民医院博士后岗位招聘
+1/37
-
天津理工大学国家杰青王铁团队招聘
+1/29
-
澳大利亚昆士兰大学化工学院招收全奖博士生2名
+1/26
-
【青岛大学】2026年生物与医药申请考核制博士生招生（含少数民族骨干人才）
+1/21
-
北京石油化工学院智能防腐涂层课题组招收2026级调剂研究生
+1/16
-
南京林业大学化学工程学院柏惺峰课题组诚聘科研助理、水杉英才E类/F类青年教师或博后
+1/7
-
江苏科技大学机械工程学院海洋装备仿生课题组招生简介
+1/5
-
武汉纺织大学全国重点实验室吕永钢教授课题组招收材料、化学、生物相关专业硕士研究生
+1/5
-
基于机器学习和人工智能的结构/合金设计-西安交大
+1/4
-
湖南农业大学 环境科学与工程0830+资源与环境专硕0857 调剂名额
+1/3
-
金属材料先进连接技术
+1/3
-
085602调剂
+1/1
-
一志愿西南交大机械专硕343求调剂
+1/1
7楼2015-08-31 16:02:44
9楼2015-09-01 08:14:29
10楼2015-09-01 08:19:15
11楼2015-09-14 11:50:36
★
小木虫: 金币+0.5, 给个红包，谢谢回帖
小木虫: 金币+0.5, 给个红包，谢谢回帖
|
本帖内容被屏蔽 |
14楼2015-09-17 14:21:15
简单回复
dmbb2楼
2015-08-31 14:57
回复
飞飞-笑笑(金币+1): 谢谢参与
2015-08-31 15:06
回复
飞飞-笑笑(金币+1): 谢谢参与
我是谁博文4楼
2015-08-31 15:15
回复
飞飞-笑笑(金币+1): 谢谢参与
2015-08-31 15:27
回复
飞飞-笑笑(金币+1): 谢谢参与
一米阳光YM6楼
2015-08-31 15:45
回复
飞飞-笑笑(金币+1): 谢谢参与
hr.wu8楼
2015-08-31 16:34
回复
fishyr12楼
2015-09-17 14:10
回复
liubopeng13楼
2015-09-17 14:11
回复
10
小白112615楼
2015-09-17 17:07
回复
1808466628316楼
2015-09-17 17:22
回复
xdon041717楼
2015-09-17 22:30
回复
William.Chen18楼
2015-09-17 23:25
回复
